A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests

被引:50
作者
Barr, Alasdair M.
Kinney, Jefferson W.
Hill, Matthew N.
Lu, Xiaoying
Biros, Shannon
Rebek, Julius, Jr.
Bartfai, Tamas
机构
[1] Scripps Res Inst, Dept Mol & Integrat Neurosci, La Jolla, CA 92037 USA
[2] Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1L8, Canada
[3] Scripps Res Inst, Dept Chem, La Jolla, CA USA
关键词
antidepressant; anxiety; galanin; GalR3; forced swim test; tail suspension test;
D O I
10.1016/j.neulet.2006.06.033
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The neuropeptide galanin is widely expressed in limbic nuclei in the brain, and plays an important role in the regulation of homeostatic and affective behaviors, in part through its modulation of central monoamine pathways. Recent evidence suggests that galanin and its receptors may be involved in the efficacy of various modalities of antidepressant treatments. We have previously demonstrated that systemically active, non-peptide galanin receptor type-1/2 agonists exhibit antidepressant-like effects in the rat forced swim test. Here we evaluate a novel galanin receptor type-3 (GalR3) antagonist in preclinical tests of anxiety and depression. At multiple doses, the compound displayed no effects in the elevated plus maze in mice. By contrast, the compound decreased time spent immobile in the tail suspension test by mice. Additionally, the GalR3 drug decreased time spent immobile in the forced swim test in rats, similarly to the effects of desipramine, yet did not increase locomotor activity in an open field test. These combined data from two species indicate that GalR3 receptor antagonists may exhibit antidepressant-like effects. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:111 / 115
页数:5
相关论文
共 30 条
[21]   A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus [J].
Lu, XY ;
Barr, AM ;
Kinney, JW ;
Sanna, P ;
Conti, B ;
Behrens, MM ;
Bartfai, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) :874-879
[22]   In vivo interaction between serotonin and galanin receptors types 1 and 2 in the dorsal raphe:: implication for limbic seizures [J].
Mazarati, AM ;
Baldwin, RA ;
Shinmei, S ;
Sankar, R .
JOURNAL OF NEUROCHEMISTRY, 2005, 95 (05) :1495-1503
[23]   DISTRIBUTION OF GALANIN-LIKE IMMUNOREACTIVITY IN THE RAT CENTRAL-NERVOUS-SYSTEM [J].
MELANDER, T ;
HOKFELT, T ;
ROKAEUS, A .
JOURNAL OF COMPARATIVE NEUROLOGY, 1986, 248 (04) :475-517
[24]   Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous system [J].
Mennicken, F ;
Hoffert, C ;
Pelletier, M ;
Ahmad, S ;
O'Donnell, D .
JOURNAL OF CHEMICAL NEUROANATOMY, 2002, 24 (04) :257-268
[25]   Intravenous administration of the neuropeptide galanin has fast antidepressant efficacy and affects the sleep EEG [J].
Murck, H ;
Held, K ;
Ziegenbein, M ;
Künzel, H ;
Holsboer, F ;
Steiger, A .
PSYCHONEUROENDOCRINOLOGY, 2004, 29 (09) :1205-1211
[26]   Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test [J].
Page, ME ;
Detke, MJ ;
Dalvi, A ;
Kirby, LG ;
Lucki, I .
PSYCHOPHARMACOLOGY, 1999, 147 (02) :162-167
[27]   Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299 [J].
Swanson, CJ ;
Blackburn, TP ;
Zhang, XX ;
Zheng, K ;
Xu, ZQD ;
Hökfelt, T ;
Wolinsky, TD ;
Konkel, MJ ;
Chen, H ;
Zhong, HL ;
Walker, MW ;
Craig, DA ;
Gerald, CPG ;
Branchek, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (48) :17489-17494
[28]   GALANIN - A NOVEL BIOLOGICALLY-ACTIVE PEPTIDE FROM PORCINE INTESTINE [J].
TATEMOTO, K ;
ROKAEUS, A ;
JORNVALL, H ;
MCDONALD, TJ ;
MUTT, V .
FEBS LETTERS, 1983, 164 (01) :124-128
[29]   Pharmacological evidence supporting a role for galanin in cognition and affect [J].
Wrenn, CC ;
Crawley, JN .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2001, 25 (01) :283-299
[30]   Galanin attenuates basal and antidepressant drug-induced increase of extracellular serotonin and noradrenaline levels in the rat hippocampus [J].
Yoshitake, T ;
Reenilä, K ;
Ögren, SO ;
Hökfelt, T ;
Kehr, J .
NEUROSCIENCE LETTERS, 2003, 339 (03) :239-242